Loading…
In vivo evaluation of [ 123I]-4-iodo- N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies
In this study, in vivo evaluation in mice and rabbits of [ 123I]-4-iodo- N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide ([ 123I]-BPB), a potential radioligand for visualisation of the sigma receptor by single photon emission computed tomography (SPECT), is reported. The compound possesses...
Saved in:
Published in: | Nuclear medicine and biology 2005-02, Vol.32 (2), p.193-200 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c435t-e303ccb590b947afb3408f390555710007d4e40e922adfeacc4164e51e5af86d3 |
---|---|
cites | cdi_FETCH-LOGICAL-c435t-e303ccb590b947afb3408f390555710007d4e40e922adfeacc4164e51e5af86d3 |
container_end_page | 200 |
container_issue | 2 |
container_start_page | 193 |
container_title | Nuclear medicine and biology |
container_volume | 32 |
creator | Staelens, Ludovicus Oltenfreiter, Ruth Dumont, Filip Waterhouse, Rikki N. Vandenbulcke, Katia Blanckaert, Peter Dierckx, Rudi A. Slegers, Guido |
description | In this study, in vivo evaluation in mice and rabbits of [
123I]-4-iodo-
N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide ([
123I]-BPB), a potential radioligand for visualisation of the sigma receptor by single photon emission computed tomography (SPECT), is reported. The compound possesses appropriate lipophilicity (log
P=2.2) and binds sigma-1 and sigma-2 receptors (pKi=6.51 and 6.79, respectively). In mice, this new radioiodinated tracer exhibited high brain uptake (4.99% ID/g tissue at 10 min postinjection) and saturable binding (3.06% ID/g tissue at 10 min postinjection) as determined by pretreatment with unlabeled [
123I]-BPB. A metabolite study demonstrated no (less than 5%) labeled metabolites in the brain. In rabbits, regional brain distribution was investigated and the tracer displayed high, homogeneous central nervous system uptake. Selectivity was assessed by competition experiments with known sigma ligands. Metabolite analysis showed no (less than 8%) labeled metabolites in the rabbit brain. In conclusion, our findings indicate that [
123I]-BPB is not a suitable tracer for visualisation of D
3 receptors while its potential for sigma receptor imaging is severely hampered by its affinity for dopamine receptors. |
doi_str_mv | 10.1016/j.nucmedbio.2004.09.007 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67447346</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0969805104001702</els_id><sourcerecordid>67447346</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-e303ccb590b947afb3408f390555710007d4e40e922adfeacc4164e51e5af86d3</originalsourceid><addsrcrecordid>eNqFUcGO0zAQtRCI7S78AviE2IPLOLGThtuqWqDSCpBYTghZjj3ZdZXYIXYqut_BB-PSCo5II814_N6M_R4hLzksOfDqzXbpZzOgbV1YFgBiCc0SoH5EFnxVF6ypuHhMFtBUDVuB5GfkPMYtZKbg8JSccVkXvK7kgvzaeLpzu0Bxp_tZJxc8DR39RnlRbr4zwVywgdGP7LX4EwUbMN2Hn_vxHv2-v2SjG3HSD84zzvK5ndOh26J_0IOz-JZqOoaEPjnd0-juBk0nNDimMNHe3WlvaZfLL5-v17c0ptk6jM_Ik073EZ-f8gX5-u76dv2B3Xx6v1lf3TAjSpkYllAa08oG2kbUumtLAauubEBKWXPIeliBArApCm071MaILABKjlJ3q8qWF-TVce44hR8zxqQGFw32vfYY5qiqWoi6FFUG1kegmUKME3ZqnNygp73ioA6GqK36a4g6GKKgUfkBmfnitGJu8_U_3smBDLg6AjB_dOdwUtE49AatyzolZYP775Lfb1efyQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67447346</pqid></control><display><type>article</type><title>In vivo evaluation of [ 123I]-4-iodo- N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies</title><source>ScienceDirect Freedom Collection</source><creator>Staelens, Ludovicus ; Oltenfreiter, Ruth ; Dumont, Filip ; Waterhouse, Rikki N. ; Vandenbulcke, Katia ; Blanckaert, Peter ; Dierckx, Rudi A. ; Slegers, Guido</creator><creatorcontrib>Staelens, Ludovicus ; Oltenfreiter, Ruth ; Dumont, Filip ; Waterhouse, Rikki N. ; Vandenbulcke, Katia ; Blanckaert, Peter ; Dierckx, Rudi A. ; Slegers, Guido</creatorcontrib><description>In this study, in vivo evaluation in mice and rabbits of [
123I]-4-iodo-
N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide ([
123I]-BPB), a potential radioligand for visualisation of the sigma receptor by single photon emission computed tomography (SPECT), is reported. The compound possesses appropriate lipophilicity (log
P=2.2) and binds sigma-1 and sigma-2 receptors (pKi=6.51 and 6.79, respectively). In mice, this new radioiodinated tracer exhibited high brain uptake (4.99% ID/g tissue at 10 min postinjection) and saturable binding (3.06% ID/g tissue at 10 min postinjection) as determined by pretreatment with unlabeled [
123I]-BPB. A metabolite study demonstrated no (less than 5%) labeled metabolites in the brain. In rabbits, regional brain distribution was investigated and the tracer displayed high, homogeneous central nervous system uptake. Selectivity was assessed by competition experiments with known sigma ligands. Metabolite analysis showed no (less than 8%) labeled metabolites in the rabbit brain. In conclusion, our findings indicate that [
123I]-BPB is not a suitable tracer for visualisation of D
3 receptors while its potential for sigma receptor imaging is severely hampered by its affinity for dopamine receptors.</description><identifier>ISSN: 0969-8051</identifier><identifier>EISSN: 1872-9614</identifier><identifier>DOI: 10.1016/j.nucmedbio.2004.09.007</identifier><identifier>PMID: 15721765</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>123I ; Animals ; Benzamides - pharmacokinetics ; Brain - diagnostic imaging ; Brain - metabolism ; Dopamine D 3 receptors SPECT ; Feasibility Studies ; Male ; Metabolic Clearance Rate ; Mice ; Organ Specificity ; Piperazines - pharmacokinetics ; Rabbits ; Radiopharmaceuticals - pharmacokinetics ; Receptors, sigma - metabolism ; Sigma receptors ; Species Specificity ; Tissue Distribution ; Tomography, Emission-Computed, Single-Photon - methods</subject><ispartof>Nuclear medicine and biology, 2005-02, Vol.32 (2), p.193-200</ispartof><rights>2005 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c435t-e303ccb590b947afb3408f390555710007d4e40e922adfeacc4164e51e5af86d3</citedby><cites>FETCH-LOGICAL-c435t-e303ccb590b947afb3408f390555710007d4e40e922adfeacc4164e51e5af86d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15721765$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Staelens, Ludovicus</creatorcontrib><creatorcontrib>Oltenfreiter, Ruth</creatorcontrib><creatorcontrib>Dumont, Filip</creatorcontrib><creatorcontrib>Waterhouse, Rikki N.</creatorcontrib><creatorcontrib>Vandenbulcke, Katia</creatorcontrib><creatorcontrib>Blanckaert, Peter</creatorcontrib><creatorcontrib>Dierckx, Rudi A.</creatorcontrib><creatorcontrib>Slegers, Guido</creatorcontrib><title>In vivo evaluation of [ 123I]-4-iodo- N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies</title><title>Nuclear medicine and biology</title><addtitle>Nucl Med Biol</addtitle><description>In this study, in vivo evaluation in mice and rabbits of [
123I]-4-iodo-
N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide ([
123I]-BPB), a potential radioligand for visualisation of the sigma receptor by single photon emission computed tomography (SPECT), is reported. The compound possesses appropriate lipophilicity (log
P=2.2) and binds sigma-1 and sigma-2 receptors (pKi=6.51 and 6.79, respectively). In mice, this new radioiodinated tracer exhibited high brain uptake (4.99% ID/g tissue at 10 min postinjection) and saturable binding (3.06% ID/g tissue at 10 min postinjection) as determined by pretreatment with unlabeled [
123I]-BPB. A metabolite study demonstrated no (less than 5%) labeled metabolites in the brain. In rabbits, regional brain distribution was investigated and the tracer displayed high, homogeneous central nervous system uptake. Selectivity was assessed by competition experiments with known sigma ligands. Metabolite analysis showed no (less than 8%) labeled metabolites in the rabbit brain. In conclusion, our findings indicate that [
123I]-BPB is not a suitable tracer for visualisation of D
3 receptors while its potential for sigma receptor imaging is severely hampered by its affinity for dopamine receptors.</description><subject>123I</subject><subject>Animals</subject><subject>Benzamides - pharmacokinetics</subject><subject>Brain - diagnostic imaging</subject><subject>Brain - metabolism</subject><subject>Dopamine D 3 receptors SPECT</subject><subject>Feasibility Studies</subject><subject>Male</subject><subject>Metabolic Clearance Rate</subject><subject>Mice</subject><subject>Organ Specificity</subject><subject>Piperazines - pharmacokinetics</subject><subject>Rabbits</subject><subject>Radiopharmaceuticals - pharmacokinetics</subject><subject>Receptors, sigma - metabolism</subject><subject>Sigma receptors</subject><subject>Species Specificity</subject><subject>Tissue Distribution</subject><subject>Tomography, Emission-Computed, Single-Photon - methods</subject><issn>0969-8051</issn><issn>1872-9614</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNqFUcGO0zAQtRCI7S78AviE2IPLOLGThtuqWqDSCpBYTghZjj3ZdZXYIXYqut_BB-PSCo5II814_N6M_R4hLzksOfDqzXbpZzOgbV1YFgBiCc0SoH5EFnxVF6ypuHhMFtBUDVuB5GfkPMYtZKbg8JSccVkXvK7kgvzaeLpzu0Bxp_tZJxc8DR39RnlRbr4zwVywgdGP7LX4EwUbMN2Hn_vxHv2-v2SjG3HSD84zzvK5ndOh26J_0IOz-JZqOoaEPjnd0-juBk0nNDimMNHe3WlvaZfLL5-v17c0ptk6jM_Ik073EZ-f8gX5-u76dv2B3Xx6v1lf3TAjSpkYllAa08oG2kbUumtLAauubEBKWXPIeliBArApCm071MaILABKjlJ3q8qWF-TVce44hR8zxqQGFw32vfYY5qiqWoi6FFUG1kegmUKME3ZqnNygp73ioA6GqK36a4g6GKKgUfkBmfnitGJu8_U_3smBDLg6AjB_dOdwUtE49AatyzolZYP775Lfb1efyQ</recordid><startdate>20050201</startdate><enddate>20050201</enddate><creator>Staelens, Ludovicus</creator><creator>Oltenfreiter, Ruth</creator><creator>Dumont, Filip</creator><creator>Waterhouse, Rikki N.</creator><creator>Vandenbulcke, Katia</creator><creator>Blanckaert, Peter</creator><creator>Dierckx, Rudi A.</creator><creator>Slegers, Guido</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050201</creationdate><title>In vivo evaluation of [ 123I]-4-iodo- N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies</title><author>Staelens, Ludovicus ; Oltenfreiter, Ruth ; Dumont, Filip ; Waterhouse, Rikki N. ; Vandenbulcke, Katia ; Blanckaert, Peter ; Dierckx, Rudi A. ; Slegers, Guido</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-e303ccb590b947afb3408f390555710007d4e40e922adfeacc4164e51e5af86d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>123I</topic><topic>Animals</topic><topic>Benzamides - pharmacokinetics</topic><topic>Brain - diagnostic imaging</topic><topic>Brain - metabolism</topic><topic>Dopamine D 3 receptors SPECT</topic><topic>Feasibility Studies</topic><topic>Male</topic><topic>Metabolic Clearance Rate</topic><topic>Mice</topic><topic>Organ Specificity</topic><topic>Piperazines - pharmacokinetics</topic><topic>Rabbits</topic><topic>Radiopharmaceuticals - pharmacokinetics</topic><topic>Receptors, sigma - metabolism</topic><topic>Sigma receptors</topic><topic>Species Specificity</topic><topic>Tissue Distribution</topic><topic>Tomography, Emission-Computed, Single-Photon - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Staelens, Ludovicus</creatorcontrib><creatorcontrib>Oltenfreiter, Ruth</creatorcontrib><creatorcontrib>Dumont, Filip</creatorcontrib><creatorcontrib>Waterhouse, Rikki N.</creatorcontrib><creatorcontrib>Vandenbulcke, Katia</creatorcontrib><creatorcontrib>Blanckaert, Peter</creatorcontrib><creatorcontrib>Dierckx, Rudi A.</creatorcontrib><creatorcontrib>Slegers, Guido</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Nuclear medicine and biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Staelens, Ludovicus</au><au>Oltenfreiter, Ruth</au><au>Dumont, Filip</au><au>Waterhouse, Rikki N.</au><au>Vandenbulcke, Katia</au><au>Blanckaert, Peter</au><au>Dierckx, Rudi A.</au><au>Slegers, Guido</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vivo evaluation of [ 123I]-4-iodo- N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies</atitle><jtitle>Nuclear medicine and biology</jtitle><addtitle>Nucl Med Biol</addtitle><date>2005-02-01</date><risdate>2005</risdate><volume>32</volume><issue>2</issue><spage>193</spage><epage>200</epage><pages>193-200</pages><issn>0969-8051</issn><eissn>1872-9614</eissn><abstract>In this study, in vivo evaluation in mice and rabbits of [
123I]-4-iodo-
N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide ([
123I]-BPB), a potential radioligand for visualisation of the sigma receptor by single photon emission computed tomography (SPECT), is reported. The compound possesses appropriate lipophilicity (log
P=2.2) and binds sigma-1 and sigma-2 receptors (pKi=6.51 and 6.79, respectively). In mice, this new radioiodinated tracer exhibited high brain uptake (4.99% ID/g tissue at 10 min postinjection) and saturable binding (3.06% ID/g tissue at 10 min postinjection) as determined by pretreatment with unlabeled [
123I]-BPB. A metabolite study demonstrated no (less than 5%) labeled metabolites in the brain. In rabbits, regional brain distribution was investigated and the tracer displayed high, homogeneous central nervous system uptake. Selectivity was assessed by competition experiments with known sigma ligands. Metabolite analysis showed no (less than 8%) labeled metabolites in the rabbit brain. In conclusion, our findings indicate that [
123I]-BPB is not a suitable tracer for visualisation of D
3 receptors while its potential for sigma receptor imaging is severely hampered by its affinity for dopamine receptors.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>15721765</pmid><doi>10.1016/j.nucmedbio.2004.09.007</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0969-8051 |
ispartof | Nuclear medicine and biology, 2005-02, Vol.32 (2), p.193-200 |
issn | 0969-8051 1872-9614 |
language | eng |
recordid | cdi_proquest_miscellaneous_67447346 |
source | ScienceDirect Freedom Collection |
subjects | 123I Animals Benzamides - pharmacokinetics Brain - diagnostic imaging Brain - metabolism Dopamine D 3 receptors SPECT Feasibility Studies Male Metabolic Clearance Rate Mice Organ Specificity Piperazines - pharmacokinetics Rabbits Radiopharmaceuticals - pharmacokinetics Receptors, sigma - metabolism Sigma receptors Species Specificity Tissue Distribution Tomography, Emission-Computed, Single-Photon - methods |
title | In vivo evaluation of [ 123I]-4-iodo- N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T13%3A40%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vivo%20evaluation%20of%20%5B%20123I%5D-4-iodo-%20N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide:%20a%20potential%20sigma%20receptor%20ligand%20for%20SPECT%20studies&rft.jtitle=Nuclear%20medicine%20and%20biology&rft.au=Staelens,%20Ludovicus&rft.date=2005-02-01&rft.volume=32&rft.issue=2&rft.spage=193&rft.epage=200&rft.pages=193-200&rft.issn=0969-8051&rft.eissn=1872-9614&rft_id=info:doi/10.1016/j.nucmedbio.2004.09.007&rft_dat=%3Cproquest_cross%3E67447346%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c435t-e303ccb590b947afb3408f390555710007d4e40e922adfeacc4164e51e5af86d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67447346&rft_id=info:pmid/15721765&rfr_iscdi=true |